MKMuhammad Ali Karamat

Muhammad Ali Karamat

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Muhammad Ali Karamat has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Abd A. Tahrani

    University of Birmingham, Birmingham, UK

    1 shared publication
  • Alan Jones

    Department of Clinical Biochemistry and Immunology, Heart of England NHS Foundation Trust, Birmingham, UK

    1 shared publication
  • Anthony H Barnett

    Department of Diabetes and Endocrinology, University Hospitals Birmingham, Birmingham, B9 5SS, UK; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK

    1 shared publication
  • Srikanth Bellary

    Department of Diabetes and Endocrinology, University Hospitals Birmingham, Birmingham, B9 5SS, UK; School of Health and Life Sciences, University of Aston, Birmingham, UK

    1 shared publication
  • Susan Elisabeth Manley

    Diabetes Translational Research Group, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; College of Medical and Dental Sciences, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK; Green Templeton College, University of Oxford, Oxford, UK

    1 shared publication
  • Umar Y. Raja

    Department of Diabetes, Queen Elizabeth Hospital, Birmingham, UK

    1 shared publication

Latest Publications

  • Ultra-long-acting insulin: a new chapter in diabetes therapy?

    by Muhammad Ali Karamat, Srikanth Bellary, Anthony H Barnett


  • Open Access

    Prevalence of undiagnosed type 2 diabetes in patients admitted with acute coronary syndrome: the utility of easily reproducible screening methods

    by Muhammad A. Karamat, Umar Y. Raja, Susan E. Manley, Alan Jones, Wasim Hanif, Abd A. Tahrani

    Despite the recognition of the importance of diagnosing dysglycaemia in patients with acute coronary syndrome (ACS) there remains a lack of consensus on the best screening modality. Our primary aims were to determine the prevalence of undiagnosed dysglycaemia and to compare the OGTT and HbA1c criteria for diagnosis of T2DM in patients admitted to hospital with ACS at baseline and at 3-months. We also aimed to investigate the role of a screening algorithm and a predictor score to define glucose tolerance in this population. A prospective study in which patients admitted with ACS to two UK teaching hospitals were assessed at baseline and 3 months follow-up. The prevalence of diabetes at baseline was 20% and 16% based on OGTT and HbA1c criteria respectively. Forty three (43) % of the patients with T2DM based on OGTT would have been missed by the HbA1c criteria at baseline. Our screening algorithm identified 87% of patients with T2DM diagnosed with OGTT. Diabetes Predictor score had better sensitivity (>80%) and negative predictive value (>90%) compared to HbA1c criteria. Two thirds of participants with IGS and a third with T2DM changed their glycaemic status at 3 months. Only 48% of the patients admitted with ACS had normo-glycaemia based on OGTT. OGTT and HbA1c identified two different populations of patients with dysglycaemia with the HbA1c criteria missing almost half the patients with T2DM based on OGTT. Compared to HbA1c criteria our diabetes algorithm and diabetes predictor score had a better correlation with OGTT criteria.